Concepedia

Pamela Vizcarra

PV

Statistics

Publications

6

Citations

166

H-Index

6

Active since

2013

Affiliations

Pfizer (United States)(Current)

Morpho (United States)

Universidad de Alcalá

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Instituto Ramón y Cajal de Investigación Sanitaria

Pamela Vizcarra is an author at Pfizer (United States) specializing in medicine, cancer biomarkers, and pathology.

ORCID

Publications per year

2013–2024

6

Publications

6

Pixelwise H-score: A novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images

Sripad Ram, Pamela Vizcarra, Pamela Whalen et al. · PLoS ONE · 2021 · 74 citations · Full text

, , +17

Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment

Donghui Huang, Dong‐Wan Kim, Αthanasios Kotsakis et al. · Genomics · 2013 · 42 citations

, , +16

Pixelwise H-score: a novel digital image analysis-based metric to quantify membrane biomarker expression from immunohistochemistry images

Sripad Ram, Pamela Vizcarra, Pamela Whalen et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 17 citations · Full text

, , +17

Detecting expression of 5T4 in CTCs and tumor samples from NSCLC patients

Steven Pirie‐Shepherd, Cory L. Painter, Pamela Whalen et al. · PLoS ONE · 2017 · 11 citations · Full text

, , +17

Impact of SARS-CoV-2 pandemic on vascular liver diseases

Anna Baiges, Eira Cerda, Caroline Amicone et al. · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · 2021 · 11 citations · Full text

, , +13

1–5 of 6